MedTrace Logo

Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds

NCT04504864 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2022-02-09

No results posted yet for this study

Summary

The purpose of this study is to investigate the safety and efficacy of low-dose (50mg) aspirin as a secondary prevention drug in patients with Non-Cardioembolic Ischemic Stroke accompanied by cerebral microbleeds.

Conditions

Interventions

DRUG

low-dose aspirin

50mg aspirin is used to prevent recurrent stroke.

DRUG

conventional-does aspirin

100mg aspirin is used to prevent recurrent stroke.

Sponsors & Collaborators

  • Shaanxi Provincial People's Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Jiaotong University

    collaborator UNKNOWN

  • Tang-Du Hospital

    collaborator OTHER

  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER

  • Xi'an Central Hospital

    collaborator OTHER

  • Xiangyang Central Hospital

    collaborator OTHER

  • Baoji Central Hospital

    collaborator OTHER

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Wen Jiang, Ph.D · Department of Neurology, Xijing Hospital, Fourth Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-02-28
Completion
2022-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04504864 on ClinicalTrials.gov